• Media

Latest News

Display # 
Title Created Date
Cannabis Science Applauds Extending Legalization of Nevada Medical Cannabis Program and Continued Growth of the U.S. Industry; Examines Opportunities Presented by the Opening of the Nevada Market 04-04-14
Cannabis Science (CBIS) Applauds Unprecedented United States Federal Government Approval of University Study of Medical Cannabis for Veterans Suffering from PTSD 18-03-14
Cannabis Science (CBIS) Announces Investors In Private Placement Include Weedmaps and Dutch Investment Company; Weedmaps and CBIS to Develop Joint Ventures and Marketing Relationship 12-03-14
Cannabis Science (CBIS) Acknowledges Dr. Sanjay Gupta, CNN Chief Medical Correspondent, for Objectively Addressing Treatment Benefits of Cannabis for Several Critical Ailments in Tonight's CNN Special: 'Weed 2' 11-03-14
Cannabis Science (CBIS) Closes Recently Announced $1 Million PPM Financing To Fund Research and Development In the U.S.A. and Europe; Funding Effort Fully Subscribed 07-03-14
Cannabis Science (CBIS) Expands into Spanish Market; Specific Focus on Medical Research and Studies 28-02-14
Cannabis Science Negotiates $1 Million Financing for Progression of Products and Start of Observational Trials 20-02-14
Cannabis Science (CBIS) Signs Partnership Agreement with Michigan Green Technologies, LLC to Focus on Reform and Proper Implementation of Cannabis and Commercial Hemp Programs for the State of Michigan 13-02-14
Cannabis Science (CBIS) Collaborates with Patients Out of Time, Inc., a Global Patient Advocacy Organization Dedicated to Educating Health Professionals and the Public about Therapeutic Cannabis 05-02-14
Cannabis Science (CBIS) Applauds U.S. Congress on Moving to Legalize Hemp Cultivation and Research; Calls Today for Final Senate Passage of Farm Bill and President's Signature into Law 04-02-14
CBIS Provides Growth Guidance on its Medicine Dispensing Systems (MDS) Exclusive & Non-Exclusive Agreements 03-02-14
Cannabis Science (CBIS) Government Affairs Representative Lobbys' with the U.S. House of Representatives' Cannabis Caucus for President Obama to Join Congressional Cannabis Caucus in Ending Federal Restrictions on Cannabinoid Research 29-01-14
Greta Gaines Former Member of the National Board of the National Organization to Reform Marijuana Law (NORML) Joins Cannabis Science (CBIS) Team to Enhance Company's Business Development Activities 28-01-14
Cannabis Science (CBIS) Announces Plans for Observational Research Study in 2014 16-01-14
Cannabis Science (CBIS) Moves Forward with Critical Support of Landmark Federal Cannabis Legislative Initiative 02-12-13
Cannabis Science Working with Cannabis Caucus in the U.S. House of Representatives in the Fight to Level the Playing Field for Cannabis Drug Research and Development 25-11-13
Cannabis Science, Inc. Announces Broad Patent Licensing Agreement with Endocan Corporation to Develop the Cannabinoid-Based Patent N2010968 'Composition for the Treatment of Neurobehavioral Disorders' for Over-the-Counter, Dispensary, and Food Products 21-11-13
Cannabis Science, Inc. (CBIS) Promotes Robert Kane to Chief Financial Officer (CFO), Board of Directors 20-11-13
Cannabis Science, Inc. (CBIS) Featured in A&U Magazine Regarding Potential Utility of Cannabinoids to Address Emerging Crisis of HIV Drug Resistance 18-11-13
Cannabis Science, Inc. (CBIS) Announces Submission of Cannabinoid-Based Patent Application N2010968 Titled 'Composition for the Treatment of Neurobehavioral Disorders' 15-11-13

Connect With Us

Facebook  Twitter  This email address is being protected from spambots. You need JavaScript enabled to view it. Go to USTREAM

People Behind the Scenes

Dr. Robert Melamede, Ph.D.
"The endocannabinoid system provides unique opportunities for regulating homeostasis to promote health with phyto-cannabinoid based pharmaceuticals."
Meet Dr. Robert Melamede, Ph.D. >